Background While emerging global classification frameworks highlight the need to redefine obesity beyond body mass index (BMI) to improve prevention strategies and public health policy, population-level applications remain scarce. We examined trends in BMI-based and newly proposed Lancet Commission definitions of obesity in the United States and South Korea, two countries with contrasting obesity trends.
Methods Using representative data from the United States National Health and Nutrition Examination Survey (NHANES, 2003–2016) and the Korea National Health and Nutrition Examination Survey (KNHANES, 2007–2023), we conducted age-standardized and age-period-cohort (APC) analyses to compare obesity trends.
Results Newly defined obesity phenotypes demonstrated a greater proportion of at-risk individuals than BMI alone, particularly among United States women and Korean men. Excess adiposity in the United States showed early increases from 55.6% to over 75%, followed by stabilization, while Korea exhibited a sustained upward trend. APC analyses revealed more divergent patterns. These sex-specific patterns align with differences in visceral adiposity by sex and in East Asian populations. Period effects on obesity were characterized by a high and sustained burden in the United States, but a more gradual yet persistent upward trend in Korea. Preclinical obesity displayed a U-shaped cohort effect in the United States, with higher prevalence in cohorts born after 1975, whereas clinical obesity continued to rise in Korea’s recent birth cohorts, especially among men.
Conclusion Our findings emphasize the utility of expanded obesity definitions and APC analysis in capturing sex-specific and generational patterns of obesity and related complications. They support adopting life-course, cohort-informed approaches in obesity prevention.
Citations
Citations to this article as recorded by
The Association Between Serum C-Reactive Protein Levels and Body Fat Parameters: Results from the Korean National Health and Nutrition Examination Survey Hyemin Jeong Medicina.2026; 62(6): 1014. CrossRef
Background The rising global incidence of type 2 diabetes mellitus (T2DM) underscores the need for predictive models that enhance early detection and prevention across diverse populations. This study aimed to identify predictors of incident T2DM within a Han Chinese population, assess their impact across various age and sex demographics, and explore their applicability to European populations.
Methods Using data from about 65,000 participants in the Taiwan Biobank (TWB), we developed a predictive model, achieving an area under the receiver operating characteristic curve of 90.58%. Key predictors were identified through LASSO regression within the TWB cohort and validated using over 4 million records from Taiwan’s Adult Preventive Healthcare Services (APHS) program and the UK Biobank (UKB).
Results Our analysis highlighted 13 significant predictors, including established factors like glycosylated hemoglobin (HbA1c) and blood glucose levels, and less conventionally considered variables such as peak expiratory flow. Notable differences in the effects of HbA1c levels and polygenic risk scores between the TWB and UKB cohorts were observed. Additionally, age and sex-specific impacts of these predictors, detailed through APHS data, revealed significant variances; for instance, waist circumference and diagnosed mixed hyperlipidemia showed greater impacts in younger females than in males, while effects remained uniform across male age groups.
Conclusion Our findings offer novel insights into the diagnosis and management of diabetes for the Han Chinese and potentially for broader East Asian populations, highlighting the importance of ethnic and demographic diversity in developing predictive models for early detection and personalized intervention strategies.
Citations
Citations to this article as recorded by
Plasminogen activator inhibitor-1, vaspin, and dietary inflammatory index in relation to cardiometabolic health in diabetic women Sule Kocabas, Nevin Sanlier Frontiers in Nutrition.2026;[Epub] CrossRef
The Relationship Between High-Density Lipoprotein (HDL) and Glycated Hemoglobin (HbA1C) in Type 2 Diabetes Mellitus Patients: Implications for Cardiovascular Risk Setyoadi Setyoadi, Dina Dewi Sartika Lestari Ismail, Annisa Wuri Kartika, Dewi Purnama Sari, Angel Dwi Septian, Adelina Stefanie Lallo, Rara Kurniasari Journal of Rural Community Nursing Practice.2025; 3(2): 234. CrossRef
Hypertriglyceridemia and decreased high-density lipoprotein cholesterol (HDL-C) persist despite statin therapy, contributing to residual atherosclerotic cardiovascular disease (ASCVD) risk. Asian subjects are metabolically more susceptible to hypertriglyceridemia than other ethnicities. Fenofibrate regulates hypertriglyceridemia, raises HDL-C levels, and is a recommended treatment for dyslipidemia. However, data on fenofibrate use across different Asian regions are limited. This narrative review summarizes the efficacy and safety data of fenofibrate in Asian subjects with dyslipidemia and related comorbidities (diabetes, metabolic syndrome, diabetic retinopathy, and diabetic nephropathy). Long-term fenofibrate use resulted in fewer cardiovascular (CV) events and reduced the composite of heart failure hospitalizations or CV mortality in type 2 diabetes mellitus. Fenofibrate plays a significant role in improving irisin resistance and microalbuminuria, inhibiting inflammatory responses, and reducing retinopathy incidence. Fenofibrate plus statin combination significantly reduced composite CV events risk in patients with metabolic syndrome and demonstrated decreased triglyceride and increased HDL-C levels with an acceptable safety profile in those with high CV or ASCVD risk. Nevertheless, care is necessary with fenofibrate use due to possible hepatic and renal toxicities in vulnerable individuals. Long-term trials and real-world studies are needed to confirm the clinical benefits of fenofibrate in the heterogeneous Asian population with dyslipidemia.
Citations
Citations to this article as recorded by
Targeting metabolic dysfunction-associated steatotic liver disease with phytosomal silymarin and piperine: A natural alternative to fenofibrate in a rat model Magdy Fouad Tawfik, Yasmin Sayed Hussein, Amany Helmy Hasanin, Walaa Baher, Nashwa El-Khazragy, Farouk Guindi Moawad, Mawada Abou El-Khair, Salwa M. El-Sayed Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(4): 5559. CrossRef
Endothelial CEPT1 Promotes Angiogenesis Through PPARα and VEGF-A Signaling Tariq J. Khan, Rodrigo Meade, Santiago Elizondo-Benedetto, Larisa Belaygorod, Omar Saffaf, Brigida Rusconi, Fong-Fu Hsu, Sangeeta Adak, Batool Arif, Mohamed S. Zaghloul, Tiandao Li, Bo Zhang, Clay F. Semenkovich, Mohamed A. Zayed Arteriosclerosis, Thrombosis, and Vascular Biology.2026; 46(1): 195. CrossRef
The novel antidiabetic medications on diabetic retinopathy: relevant molecular mechanisms, advancing diagnostic innovations, and therapeutic implications Song Wen, Chenglin Xu, Yue Yuan, Lijiao Chen, Yishu Ren, Zhimin Xu, Jianlan Jin, Jiyu Li, Ligang Zhou Frontiers in Medicine.2026;[Epub] CrossRef
Fenofibrate vs. Omega-3 in Pediatric Hypertriglyceridemia: A Randomized Controlled Trial Setila Dalili, Shahin Koohmanaee, Afagh Hassanzadeh Rad, Parnian Nemati, Habibeh Mashayekhi-sardoo, Reza Bayat, Maryam Shahrokhi Journal of Pediatric Health Care.2026;[Epub] CrossRef
Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis Jiayan Huang, Kaishun Meng, Huawei Qiu Frontiers in Endocrinology.2026;[Epub] CrossRef
Naringenin modulate peroxisome proliferator-activated receptorα (PPARα) to ameliorate hepatic ferroptosis by restoring GPX4 during liver regeneration Haoran Zhong, Lei Sun, Jiajun Yu, Yanrong Wang, Tongjie Xu, Tingfeng Yang, Liangkun Liu, Jiayuan Chen, Jinwu Liu, Hao Chen, Wenguang Fu Biochemical Pharmacology.2026; 251: 118086. CrossRef
Improved physicochemical and functional properties of soluble dietary Fiber from wheat bran by bacterial-enzymatic synergy Xiaoyu Guo, Jinghao Zhao, Peng Li, Kuijie Gong, Yuanda Song Food Chemistry.2026; 519: 149688. CrossRef
Nicotine-associated cardiovascular dysfunction: From pharmacological insights to emerging therapeutic interventions Mohammad Atiqur Rahman, Md Areeful Haque, Saisudha Koka, Krishna M. Boini Biomedicine & Pharmacotherapy.2026; 200: 119610. CrossRef
Beyond lipid-lowering effects: Challenges and insights in fenofibrate repurposing for oncology Liu Peng, Neng Zhu, Chan-Juan Zhang, Jun-Peng Long, Ya-Ning Shi, Qiong Yang, Yong-Zhen Gong, Li Qin Life Sciences.2026; 401: 124541. CrossRef
Triterpenoids from ilicis rotundae cortex ameliorate hyperlipidemia by affecting bile acids-hepatointestinal FXR axis Wei Zeng, Mengjia Sun, Jiamin Cao, Caixin Chen, Shiqin Jiang, Yuanyuan Wang, Weiqun Yang, Zhongxiang Zhao, Jing Jin Phytomedicine.2025; 139: 156537. CrossRef
Targeting of AMPK/MTOR signaling in the management of atherosclerosis: Outmost leveraging Hayder M. Al-kuraishy, Ghassan M. Sulaiman, Mayyadah H. Mohsin, Hamdoon A. Mohammed, Retaj A. Dawood, Ali K. Albuhadily, Ali I. Al-Gareeb, Salim Albukhaty, Mosleh M. Abomughaid International Journal of Biological Macromolecules.2025; 309: 142933. CrossRef
Fenofibrate ameliorates ocular surface inflammation in diabetic keratopathy Hassan Mansoor, Isabelle Xin Yu Lee, Chang Liu, Mingyi Yu, Charmaine Jan Li Toh, Victor Wei-Tsu Hsu, Fengyi Liu, Daqian Lu, Thomas Chuen Lam, Hong Chang Tan, Lei Zhou, Yu-Chi Liu The Ocular Surface.2025; 38: 31. CrossRef
An exploration of molecular signaling in drug reprocessing for Oral Squamous Cell Carcinoma Ali Nakhaei, Sarah Marzoughi, Sahar Ghoflchi, Hossein Hosseini, Amir R. Afshari, Mohammad Jalili-Nik, Prashant Kesharwani, Amirhossein Sahebkar European Journal of Medicinal Chemistry.2025; 295: 117816. CrossRef
Multi-Target Drug Strategies in the Treatment of Diabetic Retinopathy Angeline Julius, Suresh Malakondaiah, Ramalakshmi Subbarayalu, Remya Rajan Renuka, Raghu Babu Pothireddy SN Comprehensive Clinical Medicine.2025;[Epub] CrossRef
Oxidative stress and inflammatory response in cerebral infarction due to hyperlipidemia and lipid-lowering, anti-inflammatory, and antioxidant therapy Xuan Zhou, You-Quan Gu, Lei Li Journal of the Neurological Sciences.2025; 476: 123620. CrossRef
Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study Ji Yoon Kim, Nam Hoon Kim, Jiyoon Lee, Dong-Hoon Kim, Sin Gon Kim European Heart Journal - Cardiovascular Pharmacotherapy.2025; 11(7): 620. CrossRef
Online bioactivity-guided HPLC-lipoprotein lipase system with medium-high pressure chromatography for rapid recognition and targeted isolation of natural affinity agents from Nitraria tangutorum Qianyu Wu, Yu Zhang, Ce Sun, Jun Dang Journal of Chromatography A.2025; 1762: 466384. CrossRef
Combinatorial effects of Zingiber officinale and Citrus limon juices: Hypolipidemic and antioxidant insights from in vivo, in vitro, and in silico investigations Oussama Bekkouch, Ayoub Bekkouch, Hamza Elbouny, Ilham Touiss, Soufiane El Assri, Mohammed Choukri, Mohammed Bourhia, Kiryang Kim, Sojin Kang, Min Choi, Jinwon Choi, Hyo Jeong Kim, Chi-Hoon Ahn, Moon Nyeo Park, Bonglee Kim, Souliman Amrani, Muhammad Tariq PLOS One.2025; 20(9): e0319721. CrossRef
Characterizing Fenofibrate-Related Renal and Urinary Adverse Events: A Comprehensive Analysis of FDA Adverse Event Reporting System Database Li Wang, Xiangyun Jin, YanChun Li Clinical Therapeutics.2025; 47(12): 1149. CrossRef
THE EFFECT OF FENOFIBRATE ON THE DEVELOPMENT OF DIABETIC RETINOPATHY AND NEPHROPATHY – A REVIEW OF CURRENT RESEARCH Kacper Szeląg, Anna Opalińska, Cezary Lubas, Paula Folta, Joanna Kłosowska, Karolina Błądzińska, Maciej Błądziński, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski International Journal of Innovative Technologies in Social Science.2025;[Epub] CrossRef
Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT Eu Jeong Ku, Bongseong Kim, Kyungdo Han, Seung-Hwan Lee, Hyuk-Sang Kwon Cardiovascular Diabetology.2024;[Epub] CrossRef
The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review Leisheng Wang, Shiwei Xu, Mengzhen Zhou, Hao Hu, Jinyou Li International Journal of Biological Macromolecules.2024; 278: 134835. CrossRef
An exploratory investigation of lipid-lowering potential of spirulina (
Arthrospira platensis
) targeting apoprotein-E in chronic hyperlipidemic
wistar albino
rats
Anum Nazir, Mahr Un Nisa, Mohamed H. Mahmoud, Ahmed M. El-Gazzar, Eliasse Zongo Cogent Food & Agriculture.2024;[Epub] CrossRef
Advances in Understanding Diabetic Kidney Disease Progression and the Mechanisms of Acupuncture Intervention Jinyi Shan, Ziyi Cao, Siming Yu International Journal of General Medicine.2024; Volume 17: 5593. CrossRef